Havlickova 648 a.s. - 31 Dec 2024 SCHEDULE 13G/A Report for Cadrenal Therapeutics, Inc. Common Stock, par value $0.001 per share (CVKD)

Filing Manager
Havlickova 648 a.s.
Reporting Manager
Havlickova 648 a.s.
Security
Cadrenal Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
CVKD
Shares outstanding
1,783,394 shares
Disclosed Ownership
78,291 shares
Ownership
4.4%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2025, 13:05:44 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Havlickova 648 a.s. 4.4% 78,291 0 78,291 /s/ Miroslav Dornak Miroslav Dornak/Authorized Signatory
Dubnica Property s.r.o. 4.4% 78,291 0 78,291 /s/ Miroslav Dornak Miroslav Dornak/Authorized Signatory
Miroslav Dornak 4.4% 78,291 0 78,291 /s/ Miroslav Dornak Miroslav Dornak